← back to search

Clémence M. Canivet

Wenzhou Medical University · CN
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Liver Diseases and Immunity, and Hepatitis C virus research.
h-index
22
citations
1,402
works
95
NIH funding
primary concept
Medicine
email

Recent publications

Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease
Journal of Hepatology 2025cited by 33position: middledoi
Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD
Journal of Hepatology 2025cited by 29position: middledoi
From “Burnt-Out” to “Burning-Out”: Capturing Liver Fat Loss in Patients With Advanced Metabolic Dysfunction–Associated Steatotic Liver Disease From a Dynamic Perspective
Gastroenterology 2025cited by 20position: middledoi
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease
Gut 2025cited by 18position: middledoi
Long-Term Glycemic Control and the Risk of Liver Stiffness Progression and Liver-Related Events in MASLD
Clinical Gastroenterology and Hepatology 2025cited by 10position: middledoi
Association between longitudinal weight change and clinical outcome in individuals with MASLD
Hepatology 2025cited by 8position: middledoi
Cardiovascular–kidney–metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD
Hepatology 2025cited by 8position: middledoi
Management of patients with type 2 diabetes and MASLD: An overview and joint statement
Diabetes & Metabolism 2025cited by 4position: middledoi
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
JAMA 2024cited by 192position: middledoi
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease
Gut 2024cited by 77position: middledoi
New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice
Seminars in Liver Disease 2024cited by 22position: firstdoi
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study
Clinical Gastroenterology and Hepatology 2024cited by 15position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jérôme Boursier · Indiana University – Purdue University Indianapolis2 papers (2024–2025) · 1 papers (2025–2025)Jean‐Baptiste Julla · Hôpital Necker-Enfants Malades1 papers (2025–2025)Rodolphe Anty · Newcastle University1 papers (2025–2025) · 1 papers (2025–2025)Rohit Loomba · Indiana University – Purdue University Indianapolis1 papers (2024–2024) · 1 papers (2025–2025)Lawrence Serfaty · GlaxoSmithKline (India)1 papers (2025–2025) · 1 papers (2025–2025)Bruno Guerci · Cemka-Eval (France)1 papers (2025–2025)Lucia Parlati · Institut Pasteur1 papers (2025–2025)Guillaume Lassailly · Institut Pasteur de Lille1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2025–2025)Raluca Pais · University College London1 papers (2025–2025)Bertrand Cariou · University of Cape Town1 papers (2025–2025) · 1 papers (2025–2025)Laurent Castéra · Université Paris Cité1 papers (2025–2025)